Cancer risk associated with the use of valsartan in Korea: A nationwide cohort study.

Jeon, Ha-Lim; Lee, Seon Hee; Nam, Jin Hyun; Shin, Ju-Young

Jeon, Ha-Lim; Lee, Seon Hee; Nam, Jin Hyun; Shin, Ju-Young.

Afiliação

Jeon HL; School of Pharmacy and Institute of New Drug Development, Jeonbuk National University, Jeonju, Republic of Korea.
Lee SH; School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
Nam JH; Division of Big Data Science, Korea University Sejong Campus, Sejong, Republic of Korea.
Shin JY; School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea; Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, Republic of Korea; Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul, Republic of Korea. Electroni

Cancer Epidemiol ; 80: 102245, 2022 10.

Article em En | MEDLINE | ID: mdl-36087359

Assuntos

Antagonistas de Receptores de Angiotensina; Neoplasias; Antagonistas de Receptores de Angiotensina/efeitos adversos; Inibidores da Enzima Conversora de Angiotensina/efeitos adversos; Estudos de Coortes; Humanos; Neoplasias/induzido quimicamente; Neoplasias/epidemiologia; Estudos Retrospectivos; Valsartana/efeitos adversos

Palavras-chave

Angiotensin II receptor blocker; Cancer; Drug safety; Valsartan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antagonistas de Receptores de Angiotensina / Neoplasias Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google